Difference between revisions of "Etoposide (Vepesid)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 5: Line 5:
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 
==Diseases for which it is used==
 
*[[Acute lymphocytic leukemia]]
 
*[[Acute myeloid leukemia]]
 
*[[Acute promyelocytic leukemia]]
 
*[[Aggressive Non-Hodgkin lymphoma]]
 
*[[Bone cancer]]
 
*[[Unknown primary | Cancer of Unknown Primary]]
 
*[[Central nervous system (CNS) cancer]]
 
*[[Esophageal cancer]]
 
*[[Follicular lymphoma]]
 
*[[Hepatobiliary cancer]]
 
*[[HIV-associated lymphoma]]
 
*[[Hodgkin lymphoma]]
 
*[[Hodgkin lymphoma, nodular lymphocyte-predominant]]
 
*[[Mantle cell lymphoma]]
 
*[[Multiple myeloma]]
 
*[[Neuroendocrine tumors]]
 
*[[Non-small cell lung cancer]]
 
*[[Ovarian cancer]]
 
*[[Sarcoma]]
 
*[[Small cell lung cancer]]
 
*[[T-cell lymphoma]]
 
*[[Testicular cancer]]
 
*[[Thymoma]]
 
*[[Transplant conditioning regimens]]
 
  
 
==Patient drug information==
 
==Patient drug information==
Line 46: Line 20:
 
[[Category:Irritant chemotherapy]]
 
[[Category:Irritant chemotherapy]]
 
[[Category:Topoisomerase inhibitors]]
 
[[Category:Topoisomerase inhibitors]]
 +
[[Category:Acute lymphocytic leukemia medications]]
 
[[Category:Acute myeloid leukemia medications]]
 
[[Category:Acute myeloid leukemia medications]]
 +
[[Category:Acute promyelocytic leukemia medications]]
 +
[[Category:Aggressive Non-Hodgkin lymphoma medications]]
 
[[Category:Bone cancer medications]]  
 
[[Category:Bone cancer medications]]  
 
[[Category:Cancer of unknown primary medications]]  
 
[[Category:Cancer of unknown primary medications]]  
 +
[[Category:Central nervous system (CNS) cancer medications]]
 
[[Category:Esophageal cancer medications]]
 
[[Category:Esophageal cancer medications]]
 +
[[Category:Follicular lymphoma medications]]
 
[[Category:Hepatobiliary cancer medications]]
 
[[Category:Hepatobiliary cancer medications]]
 +
[[Category:HIV-associated lymphoma medications]]
 
[[Category:Hodgkin lymphoma medications]]
 
[[Category:Hodgkin lymphoma medications]]
 +
[[Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications]]
 +
[[Category:Mantle cell lymphoma medications]]
 
[[Category:Multiple myeloma medications]]
 
[[Category:Multiple myeloma medications]]
[[Category:Non-Hodgkin lymphoma medications]]
+
[[Category:Neuroendocrine tumor medications]]
 
[[Category:Non-small cell lung cancer medications]]
 
[[Category:Non-small cell lung cancer medications]]
 
[[Category:Ovarian cancer medications]]
 
[[Category:Ovarian cancer medications]]
 +
[[Category:Sarcoma medications]]
 
[[Category:Small cell lung cancer medications]]
 
[[Category:Small cell lung cancer medications]]
 +
[[Category:T-cell lymphoma medications]]
 
[[Category:Testicular cancer medications]]
 
[[Category:Testicular cancer medications]]
 
[[Category:Thymoma medications]]
 
[[Category:Thymoma medications]]
 
[[Category:Transplant medications]]
 
[[Category:Transplant medications]]

Revision as of 17:22, 11 June 2014

General information

Class/mechanism: Topoisomerase II inhibitor. Causes DNA strand breaks by interacting with DNA-topoisomerase II or by forming free radicals. Causes arrest at the G2 portion of the cell cycle, with dose dependent effects: at high concentrations, cells entering mitosis undergo lysis; at low concentrations, cells are inhibited from entering prophase.[1][2]
Route: IV, PO
Extravasation: irritant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Also known as

Abic Etoposide, Aside, Beposid, Bioposide, BO RUI, Bristol VP-16, Celltop, Citodox, Epocin, Eposid, Eposide, Eposido, Eposin, Epsidox, ETO, Etocris, Etomedac, Etonolver, Etopofos, Etopophos, Etopos, Etoposid, Etoposide Abic, Etoposid Ebewe, Etoposide Bigmar, Etoposide BVI, Etoposide Dakota, Etoposide DBL, Etoposide DUP, Etoposide Ebewe, Etoposide Eurocept, Etoposide Merck, Etoposide Pfizer, etoposide phosphate, Etoposide Teva, Etoposid Mayne, Etoposido, Etoposido Delta Farma, Etoposido Ferrer, Etoposido GI Kendr, Etoposido Servycal, Etoposido Varifarm, Etoposid Proreo, Etoposid Teva, Etopoxan, Etopul, Etosid, Etosin, Eunades CS, Euvaxon, Exitop, Fytop, Fytosid, HAI WEI LIN, Labimion, Lastet, Lastet S, Neoplaxol, Nexvep, Onkoposid, Optasid, P&U Etoposide, Percas, Posid, Posidon, Posyd, Riboposid, Sintopozid, Toposar, Toposide, Toposin, Topresid, Tosuben, Vepefos, Vepeside, Vepesid K, Vepesid S, Vepesid VP-16, Vepsid, Vepside, VP-16, VP-TEC, VP 16213

References